Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 21;26(1):71-7.
doi: 10.1021/bc500408p. Epub 2014 Dec 30.

Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting

Affiliations

Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting

Ran Lin et al. Bioconjug Chem. .

Abstract

Mitochondria are critical regulators of cellular function and survival. Delivery of therapeutic and diagnostic agents into mitochondria is a challenging task in modern pharmacology because the molecule to be delivered needs to first overcome the cell membrane barrier and then be able to actively target the intracellular organelle. Current strategy of conjugating either a cell penetrating peptide (CPP) or a subcellular targeting sequence to the molecule of interest only has limited success. We report here a dual peptide conjugation strategy to achieve effective delivery of a non-membrane-penetrating dye 5-carboxyfluorescein (5-FAM) into mitochondria through the incorporation of both a mitochondrial targeting sequence (MTS) and a CPP into one conjugated molecule. Notably, circular dichroism studies reveal that the combined use of α-helix and PPII-like secondary structures has an unexpected, synergistic contribution to the internalization of the conjugate. Our results suggest that although the use of positively charged MTS peptide allows for improved targeting of mitochondria, with MTS alone it showed poor cellular uptake. With further covalent linkage of the MTS-5-FAM conjugate to a CPP sequence (R8), the dually conjugated molecule was found to show both improved cellular uptake and effective mitochondria targeting. We believe these results offer important insight into the rational design of peptide conjugates for intracellular delivery.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1. Schematic Illustrations of (A) the Three Peptide Conjugates: MTS-5-FAM, 5-FAM-H3R8, and MTS-(5-FAM)-H3R8, and (B) Different Cellular Uptake of the Three Conjugates
MTS-5-FAM possessed α-helical secondary structure and showed no cell membrane-penetrating capability, but attaching to the cell membrane only. Cell penetrating peptide 5-FAM-H3R8 exhibited limited cellular uptake. Significant endocytosis was only observed for MTS-(5-FAM)-H3R8 containing both MTS and H3R8.
Figure 1
Figure 1
Representative flow cytometry results and circular dichroism (CD) spectra. (A) Quantitative comparison of the fluorescence intensity (in Geo mean) of three conjugates 5-FAM-H3R8 (red column), MTS-5-FAM (green column), and MTS-(5-FAM)-H3R8 (blue column) in MCF-7 breast cancer cell line after 4 h treatment with 1 μM peptide conjugates, and untreated cells were used as control. CD spectra of (B) 50 μM 5-FAM-H3R8, (C) 50 μM MTS-5-FAM (Insertion: schematic illustration of positive charge distribution in MTS, red: methionine, blue: arginine.), and (D) 50 μM MTS-(5-FAM)-H3R8. All the conjugates studied in CD analysis were dissolved in 20 mM sodium phosphate buffer (pH 7.4, with 20 mM SDS) at 37 °C.
Figure 2
Figure 2
Cellular uptake of 5-FAM-H3R8, MTS-5-FAM, and MTS-(5-FAM)-H3R8 in MCF-7 cells with lysosome (red, Lysotracker Red) and nucleus (blue, Hoechst 33342) after 4 h incubation with the respective conjugate (1 μM). An enlarged image is also included in the Supporting Information (Figure S7).
Figure 3
Figure 3
Investigation of secondary structure and its function preformed on cellular uptake study of designed peptide conjugate 5-FAM-(RLL)2R8. (A) CD spectrum of 5-FAM-(RLL)2R8. (B) Representative flow cytometry results of 5-FAM-H3R8 (red column) and 5-FAM-(RLL)2R8 (green column). (C) Cellular uptake of 5-FAM-(RLL)2R8 in MCF-7 cells with lysosome (red, Lysotracker Red) and nucleus (blue, Hoechst 33342) after 4 h incubation with the conjugate (1 μM).
Figure 4
Figure 4
Subcellular colocalization of 5-FAM-H3R8, MTS-5-FAM, and MTS-(5-FAM)-H3R8 in MCF-7 cells with mitochondria (red, Mitotracker) and nucleus (blue, Hoechst 33342) after 2 h incubation of the respective conjugates (5 μM). An enlarged image is also included in the Supporting Information (Figure S9).
Figure 5
Figure 5
Cell viability of MCF-7 breast cancer cells after 4 h treatment with 5-FAM-H3R8, MTS-5-FAM, MTS-(5-FAM)-H3R8, and 5-FAM-(RLL)2R8 at three different concentrations (1, 2, and 5 μM). The results exhibited near nontoxicity of four conjugates at all three concentrations.

Similar articles

Cited by

References

    1. Kroemer G.; Galluzzi L.; Brenner C. (2007) Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87, 99–163. - PubMed
    1. Lin M. T.; Beal M. F. (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787–795. - PubMed
    1. Fulda S.; Galluzzi L.; Kroemer G. (2010) Targeting mitochondria for cancer therapy. Nat. Rev. Drug Discovery 9, 447–464. - PubMed
    1. Abadir P. M.; Foster D. B.; Crow M.; Cooke C. A.; Rucker J. J.; Jain A.; Smith B. J.; Burks T. N.; Cohn R. D.; Fedarko N. S.; Carey R. M.; O’Rourke B.; Walston J. D. (2011) Identification and characterization of a functional mitochondrial angiotensin system. Proc. Natl. Acad. Sci. U.S.A. 108, 14849–14854. - PMC - PubMed
    1. Muratovska A.; Lightowlers R. N.; Taylor R. W.; Turnbull D. M.; Smith R. A. J.; Wilce J. A.; Martin S. W.; Murphy M. P. (2001) Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease. Nucleic Acids Res. 29, 1852–1863. - PMC - PubMed

Publication types

LinkOut - more resources